View of Clinical Outcomes of CRISPR-Cas9 Mediated Gene Editing in Patients with Sickle Cell Disease: A Biotechnology-Based Therapeutic Approach

Return to Article Details Clinical Outcomes of CRISPR-Cas9 Mediated Gene Editing in Patients with Sickle Cell Disease: A Biotechnology-Based Therapeutic Approach Download Download PDF